EU puts conditions on deals involving Novartis, GSK
The European Union on Wednesday approved mega deals involving drugmakers Novartis of Switzerland and GlaxoSmithKline of Britain, provided they sell off assets in the vaccines and consumer health businesses.
Jan 29, 2015, 00:14 AM IST